Featured Posts
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
Citation
Stearns’ Healthcare Record Questioned
From Bill Thompson’s article in The Gainesville Sun: Such remarks echo a common refrain among conservative critics of President Barack…
Daily Caller
No to Broccoli Mandate, Yes to Health Insurance Mandate?
The results of a Reason-Rupe poll that was released on Monday are more interesting than the pollsters may have intended. Two of the questions they…
Daily Caller
The Anti-GM Food Circus Rolls Through Connecticut
From the American Council on Science and Health’s “Health Facts and Fears”: But as Gregory Conko, a senior fellow at the Competitive Enterprise…
Daily Caller
Shoppers already have a choice regarding biotech foods
Consumers increasingly base food purchasing decisions on individual preferences about product content. For many, this means a focus on nutrition or fat. Others care more…
Daily Caller
How is the FDA Really Doing?
I read with interest—and mounting skepticism—Patricia Dimond’s Insight & Intelligence™ piece about FDA, “FDA New Drug Approvals in 2011 Outpace…
Daily Caller